Facebook Twitter LinkedIn Google Plus RSS

N.J. therapeutics company promotes senior leadership

By ,

Hampton-based Celldex Therapeutics Inc. has promoted three senior leaders in its clinical and research departments.

Dr. Tibor Keler has been promoted to executive vice president and chief scientific officer; Dr. Thomas Davis has been promoted to executive vice president and chief medical officer; and Elizabeth Crowley has been promoted to senior vice president, product development.

"We continue to build an exceptional team of senior leaders at Celldex who are committed to advancing our pipeline and improving the lives of patients facing cancer," Anthony Marucci, president and CEO of Celldex, said in a prepared statement. "These promotions are a direct reflection of the critical roles Tibor, Tom and Beth have played over the years in executing on these goals.”

Keler is a founder of Celldex and most recently served as its senior vice president and chief scientific officer.  Prior to that, he was senior director of preclinical development and principal scientist at Medarex.

Davis most recently served as senior vice president and chief medical officer.  Prior to that, he was chief medical officer at GenVec and senior director of clinical science at Medarex.

Crowley joined Celldex in 2009 as vice president, clinical development.  Prior to that, she held several senior leadership positions at CuraGen Corporation, most recently serving as the vice president of development operations.

ALSO ON NJBIZ:

In Denville, town rallied behind recovery from flood

Lesniak: NFL is hypocritical in its opposition to N.J. sports betting

Newark company opening temporary co-working location

You May Have Missed...

Emily Bader

Emily Bader


Emily Bader is the Web Editor and Social Media Coordinator at NJBIZ. She is a Brielle, N.J. native and a Rutgers University alum. You can contact her at emilyb@njbiz.com.

Leave a Comment

test

Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy

Comments

close